Skip to main content
Equibles
PCSA logo

PCSA · Processa Pharmaceuticals, Inc. · Options Chain

Track PCSA — free

Use PCSA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PCSA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.99 -0.17 (-7.87%) At close · Sep 9
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$5.56M
Shares
2.79M

Options Chain

Underlying $1.99 · at close Sep 9, 2026 Options Calculator
Pull option chains with greeks and open interest through the options chain API or MCP →

No listed options were found for PCSA.

Key facts CIK 1533743 CUSIP 74275C403 13F (30d) 12 filings 12 filers Visit website Investor relations